Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 329

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 329
---
 qualified board members.

As
a reporting issuer, we are subject to the reporting requirements of applicable securities legislation of the jurisdiction in which it
is a reporting issuer, the listing requirements of Nasdaq and other applicable securities rules and regulations. Compliance with these
rules and regulations will increase our legal and financial compliance costs, make some activities more difficult, time-consuming or
costly and increase demand on its systems and resources. Applicable securities laws will require us to, among other things, file certain
annual and quarterly reports with respect to its business and results of operations. In addition, applicable securities laws require
us to, among other things, maintain effective disclosure controls and procedures and internal control over financial reporting.

In
order to maintain and, if required, improve its disclosure controls and procedures and internal control over financial reporting to meet
this standard, significant resources and management oversight are required. Specifically, due to the increasing complexity of its transactions,
it is anticipated that we will improve our disclosure controls and procedures and internal control over financial reporting primarily
through the continued development and implementation of formal policies, improved processes and documentation procedures, as well as
the continued sourcing of additional finance resources. As a result, management’s attention may be diverted from other business
concerns, which could harm our business and results of operations. To comply with these requirements, we may need to hire more employees
in the future or engage outside consultants, which will increase costs and expenses.

In
addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for
public companies, increasing legal and financial compliance costs and making some activities more time consuming. These laws, regulations
and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application
in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty
regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to
continue to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general
and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance
activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing
bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us,
which could adversely affect our business and financial results.

As